A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

Salehi Retina Institute, Huntington Beach, California

Advanced Research LLC, Boynton Beach, Florida

Advanced Research LLC, Deerfield Beach, Florida

Retina Vitreous Associates of Florida, St. Petersburg, Florida

Opthamalic Consultants of Boston, Boston, Massachusetts

Australia

Novartis Investigative Site, Albury, New South Wales

Novartis Investigative Site, Parramatta, New South Wales